Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Current Medical Research and Opinion|June 2, 2011
Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposureRudy Onia, Ingrid Eshun-Wilson, Christina Arce, et al.
Gynecologic Oncology|January 22, 2023
Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trialMark H Stoler, Thomas C Wright, Valentin Parvu, et al.
Mayo Clinic Proceedings|February 10, 2015
Safety and efficacy of insulin therapy delivered via a 4mm pen needle in obese patients with diabetesRichard M Bergenstal, Ellie S Strock, Diana Peremislov, et al.
American Journal of Clinical Pathology|January 17, 2019
HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal CytologyMark H Stoler, Thomas C Wright, Valentin Parvu, et al.
American Journal of Clinical Pathology|September 7, 2018
Detection of Cervical Neoplasia by Human Papillomavirus Testing in an Atypical Squamous Cells-Undetermined Significance Population: Results of the Becton Dickinson Onclarity TrialThomas C Wright, Mark H Stoler, Valentin Parvu, et al.
Sexually Transmitted Infections|August 30, 2024
Comprehensive assessment of vaginal infections using a single swabBarbara Van Der Pol, Cheri Aycock, Paula Dixon, et al.
Gynecologic Oncology|March 12, 2019
HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: Results from the baseline phase of the Onclarity trialThomas C Wright, Valentin Parvu, Mark H Stoler, et al.
Gynecologic Oncology|April 24, 2018
The Onclarity Human Papillomavirus Trial: Design, methods, and baseline resultsMark H Stoler, Thomas C Wright, Valentin Parvu, et al.
American Journal of Obstetrics and Gynecology|October 8, 2023
Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United StatesCosette M Wheeler, Norah E Torrez-Martinez, Edith Torres-Chavolla, et al.
International Journal of Cancer|March 22, 2019
Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohortJesper Bonde, Fabio Bottari, Valentin Parvu, et al.
Pageof 3